Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.

Brain Communications
Philip S InselMichael C Donohue

Abstract

With recent advances in our understanding of the continuous pathophysiological changes that begin many years prior to symptom onset, it is now apparent that Alzheimer's disease cannot be adequately described by discrete clinical stages, but should also incorporate the continuum of biological changes that precede and underlie the clinical representation of the disease. By jointly considering longitudinal changes of all available biomarkers and clinical assessments, variation within individuals can be integrated into a single continuous measure of disease progression and used to identify the earliest pathophysiological changes. Disease time, a measure of disease severity, was estimated using a Bayesian latent time joint mixed-effects model applied to an array of imaging, biomarker and neuropsychological data. Trajectories of regional amyloid β and tau PET uptake were estimated as a function of disease time. Regions with early signs of elevated amyloid β uptake were used to form an early, focal composite and compared to a commonly used global composite, in a separate validation sample. Disease time was estimated in 279 participants (183 cognitively unimpaired individuals, 61 mild cognitive impairment and 35 Alzheimer's disease dem...Continue Reading

References

Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 1, 2011·Annals of Neurology·Victor L VillemagneChristopher C Rowe
Feb 15, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Abhinay D JoshiUNKNOWN Florbetapir F 18 Study Investigators
Oct 31, 2012·Annals of Neurology·Susan M LandauUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 25, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael C DonohueUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 28, 2015·Annals of Neurology·Keith A JohnsonReisa Sperling
Mar 5, 2016·Neuron·Michael SchöllWilliam J Jagust
Jun 21, 2016·Annals of Neurology·Hanna ChoChul Hyoung Lyoo
Jun 8, 2017·NeuroImage·Anne MaassUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 24, 2017·Statistical Methods in Medical Research·Dan LiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 9, 2018·Nature·Akinori NakamuraKatsuhiko Yanagisawa
Oct 8, 2018·Neurobiology of Aging·Stephanie A SchultzTammie L S Benzinger
Jan 15, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Niklas MattssonOskar Hansson
Jul 18, 2019·JAMA Neurology·Niklas MattssonOskar Hansson

❮ Previous
Next ❯

Citations

Aug 10, 2020·Journal of Neurochemistry·Samantha De La-RocqueGiampietro Schiavo
Sep 17, 2020·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Won-Jin MoonSeol-Heui Han
Aug 3, 2020·Journal of Neural Transmission·Kurt A Jellinger
Nov 18, 2020·Neurology·Michelle E FarrellUNKNOWN Alzheimer's Disease Neuroimaging Initiative and the Harvard Aging Brain Study
Feb 9, 2021·Journal of Alzheimer's Disease : JAD·Enrico PeiraFlavio Nobili
Oct 14, 2020·PLoS Computational Biology·Travis B ThompsonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 2, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Miriam Palomar-BonetJose L Cantero
Jan 8, 2021·Neurology·William J JagustUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 19, 2021·NeuroImage. Clinical·Helena M GellersenSaber Sami
Mar 29, 2021·Alzheimer's Research & Therapy·Santiago BullichMercè Boada
Mar 31, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rachel F Buckley
Apr 25, 2021·Neurobiology of Aging·Priya PaltaJosé A Luchsinger
May 28, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Antoine LeuzyOskar Hansson
Jun 5, 2021·Brain Communications·Clément Abi NaderUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 24, 2021·JAMA Network Open·Philip S InselR Scott Mackin
Jun 7, 2021·Aging·Wanting LiuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 5, 2021·Dementia & Neuropsychologia·Claudia Rivera-FernándezMarcio Soto-Añari
Aug 9, 2021·Psychiatry Research. Neuroimaging·Bárbara Duarte-AbrittaSalvador M Guinjoan
Aug 10, 2021·Journal of Alzheimer's Disease : JAD·Laurens Ansem van de MortelUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 29, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Dallas P VeitchUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 17, 2021·Brain : a Journal of Neurology·David BerronOskar Hansson

❮ Previous
Next ❯

Methods Mentioned

BETA
BSTS

Software Mentioned

LTJMM

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Related Papers

Brain : a Journal of Neurology
Clifford R JackRonald C Petersen
Lancet
Philip ScheltensWiesje M van der Flier
BioRxiv : the Preprint Server for Biology
Jacob ZiontzSusan M Resnick
© 2021 Meta ULC. All rights reserved